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Secondary diversification of the antibody repertoire upon antigenic challenge, in the form of
immunoglobulin heavy chain (IgH) class-switch recombination (CSR) endows mature, naïve
B cells in peripheral lymphoid organs with a limitless ability to mount an optimal humoral
immune response, thus expediting pathogen elimination. CSR replaces the default con-
stant (CH) region exons (Cµ) of IgH with any of the downstream CH exons (Cγ, Cε, or Cα),
thereby altering effector functions of the antibody molecule.This process depends on, and
is orchestrated by, activation-induced deaminase (AID), a DNA cytidine deaminase that
acts on single-stranded DNA exposed during transcription of switch (S) region sequences
at the IgH locus. DNA lesions thus generated are processed by components of several
general DNA repair pathways to drive CSR. Given that AID can instigate DNA lesions and
genomic instability, stringent checks are imposed that constrain and restrict its mutagenic
potential. In this review, we will discuss how AID expression and substrate specificity and
activity is rigorously enforced at the transcriptional, post-transcriptional, post-translational,
and epigenetic levels, and how the DNA-damage response is choreographed with precision
to permit targeted activity while limiting bystander catastrophe.
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INTRODUCTION
B cells are specialized lymphocytes that express Ig receptors (or
antibodies) on their cell surface. Antibodies are comprised of
immunoglobulin heavy chains (IgH) and light chains (IgL), with
the N-termini of IgH and IgL generating the antigen-binding
pocket, and the C-terminus of IgH performing effector functions.
A salient feature of B-lymphocytes is their ability to recognize
an almost infinite array of antigens. This enormous diversity is
achieved through V(D)J recombination, a process that assembles
the exons encoding the amino-terminal variable regions of IgH
and IgL from component variable (V), diversity (D), and join-
ing (J) segments (1). The end product of V(D)J recombination
is a mature but naïve IgM+ B cell that exits the bone marrow.
In the context of specialized structures called germinal centers in
secondary lymphoid organs such as the spleen and lymph nodes,
mature B cells interact with antigens and undergo class-switch
recombination (CSR) (2, 3).
The mouse IgH locus is comprised of eight constant region
(CH) exons, with Cµ most proximal to the variable region seg-
ments and Cα being the most distal (Figure 1). CSR exchanges
the default Cµ for an alternative set of downstream CH exons, for
example, Cγ, Cε, or Cα, so that the B cell switches from expressing
IgM to one producing a secondary antibody isotype such as IgG,
IgE, or IgA, respectively. CSR occurs between repetitive “switch”
(S) DNA elements that precede each set of CH exons. Accord-
ing to the conventional model for CSR, transcription through
S regions promotes formation of DNA:RNA hybrid structures,
such as R-loops that reveal single-stranded DNA (ssDNA) sub-
strates for activation-induced deaminase (AID)-mediated cytidine
deamination (Figure 2). The deaminated residues are processed
into DNA double-strand breaks (DSBs) by components of the
base-excision repair (BER) and mismatch repair (MMR) path-
ways (4–6). End-joining of DSBs between two S regions results
in the excision of the intervening sequence and juxtaposition of
a new set of constant region exons directly downstream of the
rearranged V(D)J segment, thereby generating Ig molecules with
the same antigen specificity but with new effector functions (2,
3) (Figure 1). Here, we will discuss the intrinsic properties of
AID, the factors commissioning its function to produce obliga-
tory DNA DSBs intermediates, and the DNA repair/end-joining
pathways that ensure productive recombination.
Germinal center B cells also undergo another AID-dependent
secondary diversification reaction termed somatic hypermuta-
tion (SHM) wherein point mutations, and sometimes inser-
tions and deletions, are introduced at a very high rate (10−2–
10−3/bp/generation) into the recombined variable region exons
encoding IgH and IgL, so as to select B cells with increased anti-
gen affinity (Figure 1). SHM requires transcription through the
variable region exons and occurs primarily, but not exclusively, at
RGYW “hot-spot” motifs where R= purine base, Y= pyrimidine
base, and W=A or T nucleotide. Details of SHM are outside the
scope of this review and have been discussed in multiple excellent
reviews [for example, Ref. (7)].
INTRINSIC PROPERTIES OF AID
Following the discovery of AID by subtractive cDNA hybridiza-
tion from the mouse CH12F3 B lymphoma cells and its proven
essentiality for SHM and CSR (8, 9), a huge amount of effort has
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FIGURE 1 | Overview of CSR. CSR is a deletional-recombination reaction between repetitive switch (S) regions (ovals) that precede each set of constant region
(CH) exons. Cytokine-induced transcription through S regions drives CSR to specific CH exons. CSR requires AID and components of the base-excision repair
(BER) and mismatch repair (MMR) pathways. Somatic hypermutation (SHM) introduces point mutations at a very high rate into variable region exons, V(D)J.
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FIGURE 2 | R-loop-based model for CSR. Transcription through S regions generates R-loop structures in which the RNA stably hybridizes to the template
strand, displacing the non-template strand as ssDNA. AID activity at R-loops generate uridines in the DNA, which are subsequently processed by BER and
MMR proteins to ultimately generate DSBs. End-joining of DSBs completes CSR. Asterisks represent nicks close to each other on opposite strands.
gone into the characterization of its enzymatic properties. Ele-
gant biochemical work using purified AID from activated splenic
B cells, recombinant GST-AID from Sf9 cells, and other epitope-
tagged forms, has shed light into the DNA deamination ability
of AID in vitro [reviewed in Ref. (2)]. These studies demon-
strated unequivocally that AID deaminates deoxycytidines (dCs)
in ssDNA, and fails to act on dsDNA, RNA, and DNA:RNA hybrids.
Additionally, it was shown that AID could deaminate dCs in the
context of transcribed dsDNA (10, 11), suggesting that access to
and activity on in vivo substrates might require transcription of the
locus. Since the crystal structure of AID has not been determined,
the field has faced a bottleneck in explicit elucidation of enzyme
biochemistry. Still, based on structural and biochemical insights
from bacterial cytidine deaminases and related DNA/RNA deami-
nases such as APOBECs, the mechanism of Zn2+-dependent catal-
ysis by the active site (H56, E58, C87, C90) residues and preference
for RGYW motif (residues 113–123) was cogently demonstrated
(12, 13).
In vitro deamination assays using recombinant GST-AID puri-
fied from insect cells suggest that AID performs processive catalysis
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(14), which leads to accumulation of multiple mutations on a sin-
gle DNA fragment, disfavoring“jumping”onto a second fragment.
This finding is in contrast to proposed distributive mode of action
based on the high net positive charge (+11 at pH 7.0) of AID that
promotes strong binding to nucleic acids (15). Nonetheless, in vitro
deamination assays performed on ssDNA substrates revealed that
AID-mediated deamination is intrinsically inefficient, haphazard,
and a “random bidirectional walk” along DNA, yielding ~3%
deamination upon hot-spot encounter (16). Such a mechanism
has likely evolved to generate a diverse array of mutations, espe-
cially to favor the selection of high affinity antibodies in vivo (16).
A note of caution to be borne in mind while interpreting these
biochemical analyses is that the bulky tag might affect inherent
properties of AID, and GST-AID does not reconstitute CSR in vivo
(17), suggesting that in vitro results may not accurately reflect the
in vivo scenario. Besides, this form of AID requires the action of
RNase A to be active in vitro, which contradicts reports of AID
purified from B cells (10), advocating for adventitious properties
unique to GST-AID. It is to be noted that AID, based on its homol-
ogy to the RNA editing enzyme APOBEC1, has been proposed to
edit mRNAs and/or micro-RNAs (miRs) required for CSR and
SHM, however, there is no experimental evidence yet to support
this notion (18). Thus, despite the limitations of AID enzyme biol-
ogy, strong genetic evidence has propelled DNA deamination as
being the generally accepted model, and this review is based on
this premise.
REGULATION OF AID EXPRESSION, LOCALIZATION, AND
STABILITY
While the primary and physiological role of AID is to introduce
DNA lesions at the Ig loci to drive antibody diversification, AID
also poses a threat to genomic integrity. Ectopic expression of
AID in non-B cells converts it into a general mutator (19, 20).
Even in B cells, mistargeted AID activity is the major underly-
ing cause behind oncogenic translocations that are hallmarks of a
large number of B cell malignancies (1, 21). Therefore, regulation
of AID expression is fundamental not only for the development
of an efficient immune system, but also for the maintenance of
genomic integrity inherent to cells expressing a mutator. Thus,
it is not surprising that AID comes outfitted with multifaceted
transcriptional and post-transcriptional regulatory mechanisms.
TRANSCRIPTIONAL REGULATION OF AID EXPRESSION
Activation-induced deaminase is encoded by the Aicda gene,
located on chromosome 6 and 12 in mice and humans, respectively.
Four highly conserved regulatory regions activate Aicda transcrip-
tion primarily in activated B cells, and restrict its expression in
other cell types (Figure 3). Region 1 is comprised of a TATA-
less promoter and enhancer elements that bind HoxC4–Oct1/2
and Sp1/3 [reviewed in Ref. (22)]. This region also contains ele-
ments that respond to estrogen and progesterone, hormones that,
respectively, activate or repress AID expression (23–25). Region
2 lies within the first Aicda intron and includes binding sites for
B-cell-specific Pax5 and E2A proteins (22). This region also har-
bors silencer elements that could bind repressors E2F and c-Myb
in a fashion unrestricted to B cells (22). Deletion of the silencer
elements drastically increases AID expression, without inducing
transcription in non-B cells, bolstering the notion of extensive
checks to AID expression (26). Region 3, approximately 25 kb
downstream of Aicda, is necessary to sustain physiological lev-
els of AID expression, likely through a BATF-binding site (22, 27,
28). Region 4 is approximately 8 kb upstream of the Aicda tran-
scriptional initiation site and contains enhancers that bind NF-κB,
STAT6, and SMAD3/4, factors that are stimulated by B cell activa-
tion (22). Recently, c-Myc was implicated in binding Region 4 to
promote robust AID expression (29, 30).
Although physiological AID expression is largely restricted to
mature B cells, its expression has also been reported in other
settings. AID is expressed in developing B cells in the bone mar-
row, inducing robust CSR to a subset of isotypes (31, 32). The
physiological relevance of CSR in the bone marrow is not clear
at present. AID expression has also been observed in intestinal
epithelial cells during Helicobacter pylori infection; whether this
represents aberrant expression or some uncharacterized response
to infection is not known (33, 34). Additionally, AID expression
has been observed in prostate cancer cells (35); such aberrant AID
expression might be correlative or causal to pathological outcomes.
It is not clear at present whether the non-B-cell-specific
expression of AID has any physiological relevance, and the AID
fate-mapping mouse does not reveal robust expression pattern
in non-lymphoid cells (36). But an intriguing finding is that
AID is expressed in primordial germ cells, in embryonic stem
(ES) cells, and also in mouse embryonic fibroblasts induced to
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FIGURE 3 |Transcriptional regulation of AID. The Aicda locus contains four conserved regulatory regions (R1–4). The first two exons (Ex1–2) and transcription
factors with the potential to bind these regions are shown. Factors with black center and white text are activators, while factors with white center and black
text are repressors.
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undergo transcription-factor-mediated reprograming (37, 38). In
this regard, AID has been posited to deaminate methylated cyti-
dine, and in concert with DNA BER, promote demethylation of
genes required for the maintenance of a pluripotent stem-cell state
(37–40). However, AID has extremely weak intrinsic activity on
5mC, and AID-deficient mice do not exhibit any overt pheno-
type or methylome changes that could be attributed to a failure in
active demethylation (41, 42). Thus, in vivo demethylation by AID
and the factors regulating AID expression in these settings remain
provocative and warrant further research.
MICRO-RNA-MEDIATED REGULATION OF AID EXPRESSION
Another level of regulation exists at the level of stability of Aicda
mRNA, enforced by miRs such as miR-155, miR-181b, and miR-
361, with miR-155 being the best characterized. miR-155 expres-
sion is upregulated upon activation for CSR. The 3′-untranslated
region (3′-UTR) of Aicda mRNA has a binding site for miR-155,
mutation of which, increased AID expression and doubled the fre-
quency of CSR (43, 44). Surprisingly, although miR-155-deficient
B cells upregulate AID expression, they do not undergo increased
CSR, perhaps due to dysregulation of other miR-155 targets rel-
evant to CSR (45). The 3′-UTR of Aicda mRNA also contains a
binding site for miR-361 (46). Significantly, the transcription fac-
tor Bcl6, required for formation of germinal centers, binds and
transcriptionally represses both miR-155 and miR-361, in turn
relieving repression of AID (46). The role, if any, of miR-361 in
the regulation of AID mRNA stability remains to be determined.
Finally, ectopic expression of miR-181b in activated murine B
cells impaired CSR, likely due to reduced AID mRNA and pro-
tein levels (47). Given the emerging significance of canonical and
non-canonical miR targeting, it can be conceived that many more
miRs affecting AID and CSR are awaiting discovery (48).
SUBCELLULAR LOCALIZATION AND STABILITY
A rational way to constrain AID activity on DNA is by regulat-
ing its subcellular localization. AID localization is governed by
active nuclear import, cytoplasmic retention, and efficient nuclear
export. The majority (greater than 90%) of AID is sequestered in
the cytoplasm, possibly through interactions of the C-terminus
of AID with eEF1A, chaperone Hsp90, and co-chaperone Hsp40
DnaJa1 (49). Nuclear entry of AID is dependent on importin-3
and a conformational nuclear localization signal (NLS) gener-
ated upon folding; a predicted bipartite NLS at the N-terminus of
AID might not be functional (49) (Figure 4). In the nucleus, AID
was recently found to accumulate in nucleolar structures where it
associates with nucleolin and nucleophosmin (50). Mutations that
abrogated AID localization to these structures resulted in reduced
levels of CSR (50). The nucleoli may serve as a nucleation site for
forming complexes, but the precise role of nucleolar AID remains
unresolved.
A mutator protein’s presence in the nucleus must be vig-
ilantly regulated, and a nuclear export signal (NES) within
the last 10 amino acids at the C-terminus of AID mediates
CRM1-dependent active nuclear export (49) (Figure 4). Muta-
tions in the NES increased levels of nuclear AID, enhanced
SHM, but severely impaired CSR, indicating that NES-bearing
C-terminus of AID plays a role in CSR beyond export, perhaps
in mediating CSR-specific interactions (49). Consistent with this
notion, replacement of the C-terminus of AID with a heterolo-
gous NES rescued nuclear export, but did not reconstitute CSR
(51). Strikingly, the stability of AID was often compromised upon
manipulation of the C-terminus of AID, even when nuclear export
remained unaffected (51). In this regard, the half-life of nuclear
AID is significantly shorter than its cytoplasmic counterpart (~2.5
vs. ~18 h) (52). This is largely due to interactions of AID with
the proteasome through ubiquitination or Reg-γ-mediated escort
(52, 53). Overall, the involvement of the C-terminus of AID in
mediating nuclear export, protein stability, cytoplasmic reten-
tion, and CSR-specific interactions render this region one of the
most fascinating, yet complicated domain that demands extensive
examination.
AID PHOSPHORYLATION
Numerous putative phosphorylation sites in AID have been impli-
cated in regulating its ability to effect CSR, SHM, and oncogenic
translocations,without affecting stability or deamination potential
• Inhibits CSR
• Inhibits SHM
• Inhibits
c-Myc/IgH
transloca!ons
• Promotes CSR
• Promotes SHM
• Promotes CSR
• Promotes SHM
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FIGURE 4 | Notable AID domains and residues. Primary structure of AID protein with pertinent domains, motifs, and residues indicated. Panels outlined in
black briefly describe functional impact of validated phosphorylation sites.
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(Figure 4). Unfortunately, for most, mechanistic insights of func-
tional pertinence remain elusive. Physiologically relevant sites that
play critical to modest roles in AID function include serine-3 (S3),
threonine-140 (T140), and S38 (54–58). Serine-3 was identified
as a site phosphorylated by protein kinase C (PKC) in vitro (55).
In contrast to other validated phosphorylation events, phosphory-
lated S3 inhibits AID function. Mutation of S3 to alanine enhances
CSR, SHM, and c-Myc/IgH translocations, despite unperturbed
catalytic activity (55); however, the mechanistic underpinnings
remain unresolved. PKC can also phosphorylate T140, and T140A
mutation perturbs SHM more profoundly than CSR. The mech-
anism through which phosphorylation at T140 differentially reg-
ulates SHM and CSR remains unclear (56). Phosphorylation of
AID at serine-38 has been extensively characterized and will be dis-
cussed later. Overall, the regulatory mechanisms discussed above,
and processes that mediate substrate specificity in vivo as discussed
below, impose checkpoints in maintaining physiological functions
of AID to facilitate successful and efficient CSR.
ACCESSIBILITY AND TARGETING OF AID
Since AID is an ssDNA deaminase, mechanisms must exist to gen-
erate and reveal such structures at S regions during CSR. Addition-
ally, AID must be actively and specifically recruited to S regions,
not only to be productively engaged in CSR, but also to reduce
collateral damage associated with expression of a mutator pro-
tein. The nature of S regions and their transcription promote AID
accessibility to DNA while several proteins have been implicated
to specifically recruit AID to the IgH locus during CSR.
S REGIONS, TRANSCRIPTION, AND R-LOOPS
S regions are 1–12 kb repetitive sequences that are enriched with
AID “hot-spot” 5′-RGYW-3′ motifs (59, 60), and are particularly
G-rich on the non-template strand. Evidence for the role of S
regions came from elegant genetic studies wherein deletion of Sµ
dramatically impaired CSR to all isotypes while deletion of Sγ1
abolished CSR to IgG1 (61–63). Recent studies have provocatively
suggested that apart from the default donor Sµ, even Sγ1 can serve
as a donor and allow sequential switching to IgE (64), an idea that
was suggested two decades back when double-isotype expressing
B cells were identified (65–68).
The ability of S regions to serve as recombination targets
is intricately linked with “germ-line” transcription, an essential
prerequisite for CSR (2, 3). Each set of CH exons is an indepen-
dent transcriptional unit, comprised of an intervening (I)-exon,
intronic S region, and the CH exons (Figure 5). The primary
transcripts produced constitutively (via µ promoter) or inducibly
(for other CH exons), are spliced and polyadenylated but have
no protein-coding capacity. These are referred to as germ-line or
sterile transcripts. Differential stimulation with distinct sets of
activators and cytokines, provided by helper-T cells or through
direct interaction with pathogens, induces transcription through
different CH exons and promotes CSR to that particular isotype.
Significant progress in our understanding of CSR came from
ex vivo studies wherein splenic B cells were activated in culture
under different conditions. For example, bacterial lipopolysac-
charide (LPS) induces germ-line transcription through Cγ2b and
Cγ3 and allows CSR to IgG2b and IgG3, while a combination
Transcripon Unit
Primary Transcript
Processed Sterile 
TranscriptAAAA
I
x
CH Exons
Sx
Sx
P
FIGURE 5 | CH exons as transcription units. Each set of CH exons is an
independent transcription unit comprised of a promoter (P), an intervening
I-exon, an intronic-switch (S) region, and CH exons. The primary transcript is
spliced and polyadenylated but does not have protein-coding capacity, and
is thus referred to as a sterile transcript.
of LPS and interleukin-4 induces Cγ1 and Cε transcription and
CSR to IgG1 and IgE. Mutational analyses that altered or deleted
the I-exon promoter perturbed CSR dramatically, thus providing
experimental evidence for the strong mechanistic link between
germ-line transcription and fulfillment of CSR (2, 3).
It is generally believed that transcription through S region
sequences promotes formation of R-loops, wherein the template
strand stably hybridizes with the G-rich primary transcript (69,
70). This allows the non-template strand to be looped out as
ssDNA, providing an ideal substrate for AID (2) (Figure 2). Com-
pelling work in support of the R-loop model came from the
observations that a transcribed synthetic DNA fragment with a
G-rich non-template strand can support AID deamination in vitro
and CSR in B cells, while the inverted sequence (C-rich non-
template strand) that does not form R-loops, neither supports
AID-mediated deamination in vitro nor CSR in vivo (10, 63). It
is to be noted that although the role for germ-line transcription
has been well-studied, a possible role of the transcript per se was
suggested from the observation that perturbing splicing of pri-
mary switch transcripts without affecting transcription impedes
CSR (71, 72). However, the neomycin-resistance cassette used in
targeting the splice donor site was not removed, leaving open the
possibility that the observed CSR defect was due to non-specific
effects of this cassette in the IgH locus. Despite this potential
caveat, given how non-coding RNAs like HOTAIR and Xist drive
PRC2 targeting (73, 74), it would not be surprising if these non-
coding switch transcripts play a significant role in AID targeting
and activity at S regions.
FACTORS PROMOTING TEMPLATE STRAND DEAMINATION
The R-loop model does not account for the mechanism of tem-
plate strand deamination by AID, a prerequisite for the formation
of DSBs. Several models have been put forward to account for
deamination of template strand. Anti-sense transcription through
the IgH locus has been proposed to facilitate access of AID to
the template strand (75); however, anti-sense transcription is not
essential for CSR (76). Components of the RNA exosome com-
plex have been shown to interact with AID and mediate acces-
sibility to the template strand by degrading the nascent RNA
hybridized to the template strand (77). Recent work cogently
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elucidated that Nedd4-dependent ubiquitination modulates the
fate of AID-associated RNA polymerase II (Pol II), thus generat-
ing free 3′-ends that serve as substrates for RNA exosomes (78).
RNaseH has also been proposed to facilitate R-loop collapse to
ensure template strand deamination (79). However, the kinet-
ics of such R-loop degradation must be stringently regulated in
the context of S regions to first allow AID to act on the non-
template strand, and elucidation of such intricacies awaits future
work.
TARGETING AID TO DNA
The primary sequence of S regions, transcription, and R-loops set
a platform favorable for AID activity. However, for AID to reach
this platform inside the nucleus is analogous to finding a nee-
dle in a haystack. Although AID-instigated off-target breaks are
incurred, the frequency is far less than what is observed for the
Ig loci (80–82). The low abundance of AID at the non-Ig genes
has led to the debate whether this represents true binding or mere
background creeping into the chromatin immunoprecipitation-
sequencing (ChIP-seq) analysis used in these experiments (83).
While genome-wide occupancy studies suggested that AID asso-
ciates with accessible chromatin at stalled promoters of transcribed
genes (82), reanalysis of the same data set (83) contradicted the
notion of genome-wide AID binding. The technicalities and sub-
tleties of data normalization for ChIP-Seq studies seem to be at the
heart of such disparate results, and do highlight the need for cau-
tion when interrogating chromatin binding of proteins with low
nuclear abundance (83). Thus, while both genome-wide (82) and
locus-specific ChIP (10, 81, 84) clearly show abundance of AID at
the Ig loci, the efficiency of its binding to other genomic sequences
needs to be re-evaluated. Nonetheless, AID-induced mutations at
non-Ig genes are observed in even normal B cells (80). Thus, it
is obvious that the process is stringently orchestrated to prevent
bystander damage by AID. Several elements within the Ig loci have
been implicated in targeting AID to the variable region exons dur-
ing SHM (85); however, in this review we will primarily describe
the factors that chaperone AID with exquisite precision to the S
regions during CSR.
Activation-induced deaminase was shown to be in a complex
with Pol II (84), and more specifically with Spt5, a Pol II-associated
protein mechanistically linked to transcriptional pausing (81).
Genome-wide Spt5 occupancy correlated significantly with stalled
Pol II and was predictive of AID-dependent mutations. B cells
depleted of Spt5 had a severe defect in CSR, a consequence of
decreased AID binding to S regions (81). A comprehensive trea-
tise on the role of RNA pol II pausing at S regions during CSR
has been reviewed elsewhere (86). The germinal center-specific
GANP protein has also been implicated in mediating AID–Spt5–
Pol II interaction (87). However, GANP deficiency does not impair
CSR. Thus, in the context of switching B cells, there might be
other unidentified players that facilitate AID targeting to stalled
Pol II, and recent studies have shown that members of the Pol
II-associated factor 1 (PAF1) complex and histone chaperone
FACT complex can promote immune diversification by regulating
association of AID with Pol II (88).
The 14-3-3 adaptor proteins have been implicated in recruit-
ing AID to DNA through their ability to interact with RGYW
sequences (89). It is unclear and somewhat counterintuitive as
to what happens to 14-3-3 proteins after they chaperone AID to
DNA, and why they do not compete directly with AID for DNA
binding. Additionally, recent data suggests that 14-3-3 proteins
perform scaffolding function by directly interacting with uracil
DNA glycosylase (UNG) and protein kinase A (PKA), two pro-
teins with well-established functions in CSR (90–92). Besides, the
data implicate an AID C-terminus-dependent complex formation
with 14-3-3 and subsequent targeting, but they fail to reconcile
how an AID ∆189–198 mutant that is impaired in 14-3-3 bind-
ing, can be targeted to the S regions and generate mutations (93).
Future work is warranted to unequivocally establish the role of the
14-3-3 adaptors in AID targeting.
Polypyrimidine-tract-binding protein-2 (PTBP2) was identi-
fied as an AID interactor that regulates AID targeting to S regions
(94). Originally known to be a splicing regulator in brain (neu-
ronal isoform, nPTB), this protein also interacted with both the
sense and anti-sense S region transcripts in primary B cells under-
going CSR. Since splicing might be important for CSR (71), it is
tempting to speculate a splicing regulation-associated function of
PTBP2 in AID recruitment to S regions. Molecular insights into
PTBP2-dependent regulation of AID targeting, and the fate of
nuclear AID in the absence of PTBP2 will surely constitute the
next phase of investigation.
ROLE OF CHROMATIN MODIFICATIONS IN TARGETING AID
It is becoming increasingly clear that epigenetic marks play cru-
cial roles in mediating S region accessibility (95, 96). Both donor
and acceptor S regions are specifically enriched for acetylation
and methylation marks at histones H3 and H4, generally associ-
ated with “open” chromatin, for example, H3K9/K14ac, H3K27ac,
H4K8ac, and H3K4me3. It has been suggested that AID target-
ing to Sµ is facilitated by the H3K9me3 mark, which tethers AID
to the donor S region via the HP1–KAP1 complex (97). Addi-
tionally, PTIP, a component of the mixed-lineage leukemia-like
complexes that are important regulators of H3K4 methylation,
participates in CSR by regulating transcription-coupled chro-
matin accessibility. PTIP-deficient B cells have a severe defect in
CSR due to decreased germ-line transcription of downstream CH
exons, and compromised DNA repair (98). Finally, combinatorial
H3K9ac and H3S10 phosphorylation (H3K9acS10ph), specifi-
cally in the recombining S regions, deposited by GCN5/PCAF
in stimulated B cells, leads to 14-3-3 adaptor-dependent AID
binding to permit efficient CSR (96). However, it is to be noted
that these chromatin marks are not likely to be unique to S
regions, and thus cannot be sole determinants of regions per-
missive to AID activity. Interestingly, it has been shown that
R-loops are tightly linked to H3S10ph, a chromatin condensa-
tion signature (99). Thus, it can be posited that R-loop formation
facilitates H3S10ph chromatin modification, which in combina-
tion with H3K9me3 and H3K9ac marks, permits AID-mediated
in vivo deamination of S region targets. The precise interplay of
chromatin “writers,” “erasers,” and “readers” that regulate these
events warrants further investigation, but it is unambiguous
that this complex recombination reaction must be impeccably
tuned by such epigenetic controls to prevent collateral damage
by AID.
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GENERATION OF DOUBLE-STRAND BREAKS DOWNSTREAM
OF DNA DEAMINATION
All the regulatory mechanisms alluded to above serve to gener-
ate AID-instigated dU lesions in S regions. Since CSR proceeds
through DSB intermediates, the deaminated S regions need to be
processed into DNA nicks, with two closely opposed nicks consti-
tuting a DSB (2, 3). This is achieved by components of the BER
and MMR pathways.
ROLE OF BER AND MMR PATHWAYS
According to the prevailing model for CSR, UNG, a component
of the BER pathway, removes the uracil base from deaminated S
regions. The abasic site thus generated is converted into a nick
by the apurinic/apyrimidinic endonuclease APE1. Two closely
spaced nicks on opposite strands constitute a staggered DSB,
further processing of which by nucleases or DNA polymerases
(fill-in) generates a blunt DSB that can participate in end-joining
(4, 5, 100). Consistent with this model, mutations in UNG lead
to a severe defect in CSR, likely as a consequence of impaired
formation of DSBs in S regions [reviewed in Ref. (2, 3)]. Addi-
tionally, APE1± mice and APE1-deficient CH12 cells reflected
decreased DSBs in S regions and compromised CSR (101, 102).
Components of MMR pathway have also been demonstrated to
process DNA during CSR through the ability of Msh2:Msh6 to
bind dU:dG mismatches, and subsequently recruit exonuclease 1
(exo1) to potentially process nicks and ssDNA gaps into DSBs.
Indeed, mutations in Msh2 and Exo1 alter S region junctions and
significantly impair CSR [reviewed in Ref. (2, 3)]. Conversely, defi-
ciency of Pms2 and Mlh1, other members of the MMR machinery,
lead to increased microhomology at S region junctions, suggest-
ing that they might act to suppress alternative end-joining (103,
104). However, UNG mutations have a more profound effect on
CSR than mutations in MMR proteins, suggesting that CSR is
more reliant on the UNG-dependent steps. Whether this reflects
an uncharacterized preference for one pathway over the other
or supports a proposed non-canonical role for UNG, indepen-
dent of uracil removal activity during CSR, remains an open
question (105).
GENERATION OF HIGH DENSITY OF DSBs: REQUIREMENT OF AID
PHOSPHORYLATION AT SERINE-38
The cellular DNA end-joining machinery is highly efficient and
it is conceivable that a single DSB at an S region will be repaired
before it can synapse with and ligate to a downstream DSB (106).
It has therefore been speculated that efficient CSR would require
a high density of DSBs at S regions to promote productive long
distance synapsis and recombination between acceptor and donor
S regions over intra-switch re-ligation (92), a phenomenon com-
monly observed in B cells that have initiated CSR but failed to
complete the process (2). Recent studies have suggested that AID
phosphorylated at serine-38 (S38) by PKA interacts with APE1
to actively generate a high density of breaks, a likely prerequisite
for CSR (92, 107). In keeping with this notion, mutation of S38 to
alanine severely impairs CSR due to a failure to efficiently generate
DSBs at S regions (54, 56–58, 92, 107, 108).
Strikingly, AID phosphorylation at S38 was stimulated by DSBs
(107). Thus, AID phosphorylation at S38 is both required for,
and dependent on DSBs. This suggests the existence of a positive
feedback loop wherein a low density of DSBs leads to AID phos-
phorylation, APE1 binding, and amplification of DSBs that feed-
back into the loop (Figure 6). It was also demonstrated that
ATM, a protein critical for cellular response to DNA-damage,
participates in sensing the DSBs at S regions, thereby promot-
ing AID phosphorylation and APE1 interaction (107). Being a
pAID
APE-1
AID AID AIDAID
AID AID AIDAID
Few DNA breaks;
ATM ac!va!on;
pS38-AID/APE1
Increased DNA breaks
Addi!onal
pS38-AID/APE-1
AID AIDAID pAID
APE-1
AID
pAID
AID
APE-1
Ineﬃcient Eﬃcient
CSR
pAID
pAID
AID
APE-1
APE-1
pAID AID pAIDpAID
APE-APE-
APE-1
APE-1
Posi!ve
feedback
loop
pAID
APE-1
pS38-AID
ATM
PKA
APE1
DSB
11
FIGURE 6 | A phosphorylation-dependent positive feedback loop drives
CSR. Assembly of AID at S regions induces low-density DSBs and leads to
inefficient CSR, but ATM activation. This results in PKA-dependent AID
phosphorylation at serine-38, which promotes interaction of AID with APE1.
Active recruitment of APE1 to DNA accentuates DSB formation, which in turn
induces phosphorylation of additional molecules of AID, thereby perpetuating
the DSB amplification loop. This promotes the generation of high density of
DSBs at S regions that is required for CSR.
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master regulator of the DNA-damage response, it is possible to
envision ATM as a molecular rheostat that fine tunes DSB forma-
tion with efficient repair/recombination and allows safeguarded
CSR while minimizing translocations. This is reminiscent of the
role of RAG proteins in orchestrating V(D)J recombination by
generating DSBs and efficiently channeling them to productive
recombination, keeping translocation risks at bay (109–111). Sim-
ilar to RAG-dependent coordination of break induction and repair,
AID phosphorylated at S38 not only facilitates break formation,
but also interacts with the ssDNA-binding protein, replication
protein A, and likely enforces DNA repair pathways during CSR
(112, 113).
Phosphorylation at S38 actively integrates AID functions into
steps downstream of DNA deamination; however, several key
questions remain elusive. First, the factors that facilitate APE1
binding to pS38AID need to be identified. Second, the regula-
tory mechanisms that couple chromatin sensing to DNA-damage
signaling remain a mystery. Based on the recent finding of KAT5
(TIP60) tyrosine phosphorylation by DNA-damage to facilitate
H3K9me3 binding and subsequent acetylation of ATM (114), it
can be conjectured that such a pathway might be involved in
the context of S regions and CSR, where the H3K9me3 mark
has been shown to play a vital role (97). Finally, the steps
between ATM activation and PKA-dependent AID phosphoryla-
tion remain a black box. These questions remain an active area of
investigation.
COMPLETION OF CSR: END-JOINING OF SWITCH-REGION
DSBs
Double-strand breaks generated at two distinct S regions are
synapsed and ligated by end-joining during the completion phase
of CSR (115). Below, we discuss the DSB response and DNA
end-joining pathways that participate in this process.
DSB RESPONSE DURING CSR
During the general DNA-damage response, DSBs are rapidly
recognized by the Mre11–Rad50–Nbs1 (MRN) complex (116)
(Figure 7). Nbs1 recruits and activates ATM, which phosphory-
lates H2AX. Phosphorylated H2AX (γH2AX) serves as a docking
site for several DNA response proteins and promotes the rapid
accumulation of 53BP1, Nbs1, and MDC1 into repair foci near
DSBs (116). Deletion or mutation of Nbs1, H2AX, 53BP1, and
ATM impaired CSR, indicating that the proteins that participate in
sensing and transducing DSBs participate in CSR (116). Addition-
ally, the ATM-dependent DNA-damage response is required for
maintenance of genomic integrity and suppression of oncogenic
translocations, possibly through enforcing cell-cycle checkpoints
(116). Overall, ATM promotes the assembly of macromolecular
foci that stabilize DNA ends and facilitate the recruitment of repair
factors to ensure productive CSR while preventing oncogenic
translocations.
Among the ATM-activated DSB response factors, 53BP1 defi-
ciency leads to the most pronounced defect in CSR (116). CSR
AID/MMR/BER
IgH Non-IgH
HR repair pathway
Genomic instability 
53BP1 / Rif1-mediated end protec!on  
NHEJ repair pathway
A-EJ repair pathway
Class switch recombina!on 
Ku, DNA-PKcs, Artemis,
Artemis, 
XLF/Cernunnos, XRCC4 and Lig4
Parp1, Mre11, CtIP, 
XRCC1 and Lig3
XRCC2
ATM-dependent DSB response
γH2AX 
MDC1
RNF8
RNF168
MMSET
H4K20me2 
H2AK15ub
NHEJ-mediated DSB repair
FIGURE 7 | DSB response during CSR. The combination of AID, BER, and
MMR proteins generate DSBs physiologically at the IgH locus and aberrantly
at non-Ig regions, leading to activation of the cellular DNA-damage response
pathways. 53BP1 is recruited to DSBs by directly binding to H4K20me2 or
through the γH2AX–RNF8–RNF168 node (see text for details).
53BP1-dependent end protection facilitates ligation of two S regions by NHEJ
and/or A-EJ. Collateral damage induced by AID at non-Ig genes is repaired by
NHEJ and by XRCC2-dependent homologous recombination.
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requires “synapsis” or close juxtaposition of donor and acceptor
S regions (115, 117) and 53BP1 has been proposed to promote
the synapsis of broken S regions during CSR (118). Furthermore,
53BP1 has been shown to associate with Rap1-interacting factor 1
(Rif1) to protect broken DNA ends from resection. Absence of Rif1
in B cells leads to increased DNA end resection, virtually pheno-
copying 53BP1 deficiency and providing functional significance
to the 53BP1–Rif1 interaction during CSR (119–121). A recent
study elegantly teased apart differential roles of distinct phospho-
protein interactions of 53BP1, and convincingly illustrated that
Rif1 serves as an effector of productive repair, whereas PTIP wards
against mutagenic repair. This study clearly demonstrated that
53BP1 is a key player at the crossroads of efficient/aberrant DNA
repair pathway choice (122).
The chromatin microenvironment strongly influences the DSB
response. Two mechanisms have been proposed to regulate 53BP1
recruitment to DSBs in the context of chromatin. The first relies on
its interaction with H4K20me2. Methylation of H4K20 and subse-
quent 53BP1 recruitment to sites of DNA-damage is regulated by
MMSET, a histone methyltransferase (123, 124). MMSET deple-
tion in the CH12F3 B cell line decreases H4K20me2 levels, attenu-
ates 53BP1 accumulation at S regions, and impairs CSR (123). The
other process that recruits 53BP1 to DSBs requires the RING finger
protein 8 and 168 (RNF8 and RNF168)-dependent histone ubiq-
uitination pathway. RNF8 is recruited to ATM-phosphorylated
MDC1 bound to γH2AX at the site of DSBs and catalyzes
ubiquitin-dependent recruitment of RNF168 to chromatin flank-
ing the DSBs (125). Recently, 53BP1 has been shown to recog-
nize DNA-damage-induced H2A Lys15 ubiquitination catalyzed
by RNF168, revealing the mechanism of RNF8/168-dependent
recruitment of 53BP1 at DSBs. RNF8 deficiency compromised
recruitment of 53BP1 to S regions in activated B cells and sig-
nificantly impaired CSR. Additionally, inactivation of RNF168
impaired CSR in mice (126–129). Taken together, these obser-
vations suggest that 53BP1 recruitment plays a critical DSB
end-protecting role during CSR.
DNA END-JOINING
Non-homologous end-joining (NHEJ) is the primary mecha-
nism used for end-joining during CSR (2). The canonical NHEJ
machinery includes the Ku70/Ku80 heterodimer (Ku), DNA-
dependent protein kinase catalytic subunit (DNA-PKcs), Artemis,
XRCC4-like factor (XLF or Cernunnos), XRCC4, and DNA ligase
IV (Lig4). Mutations in NHEJ components including Ku70/80,
XRCC4, and DNA ligase IV severely compromise CSR. The role
of NHEJ proteins in CSR is also evident from the observations
that mutations in DNA-PKcs, artemis, and XLF lead to high levels
of chromosomal IgH breaks and translocations, even in instances
where CSR frequency is not severely impacted (116). Our current
knowledge however, does not uncover how the initial recognition
of DSBs by the MRN complex leads to the binding of Ku and
DNA-PKcs to the broken DNA.
Non-homologous end-joining-deficiency does not abolish
CSR, and S junctions in NHEJ-deficient B cells reveal extended
microhomology, leading to the proposal that an alternative
end-joining process (A-EJ) ligates DSBs during CSR (116). No fac-
tors unique to A-EJ have yet been characterized; several proteins
involved in other DNA repair pathways have been implicated to
function in A-EJ, including Mre11 and CtIP. Mre11 and CtIP have
been implicated to trim broken DNA ends to uncover micro-
homology regions, generating short stretches of complementary
nucleotides at DNA breaks, thereby promoting A-EJ during CSR
(116). In CH12F3 cells, CtIP depletion impaired CSR to IgA and
reduced the overall length of microhomology at the S junctions
(130, 131). Notably, CtIP-deficient B cells undergo normal CSR
to IgG1 (132). Therefore, elucidation of the role of CtIP in CSR
requires further investigation. A major open question relates to the
interplay between NHEJ and A-EJ: does A-EJ operate in presence
of intact NHEJ and does it have a physiological role other than
being a mere backup to NHEJ?
ROLE OF HOMOLOGY-DEPENDENT REPAIR IN RESOLVING AID-INDUCED
BREAKS DURING CSR
It has been reported that AID instigates formation of widespread
DSBs throughout the genome in activated B cells, albeit at sig-
nificantly lower levels than that at the IgH locus (133–136). Such
off-target DSBs at non-IgH loci are the major underlying lesions
contributing to translocations between IgH and non-IgH loci
(such as c-Myc) in B cells and are largely responsible for the
ontogeny of a large number of B cell lymphomas in humans
(21). In addition to aberrant translocations, AID can also induce
somatic mutations at numerous loci linked to B cell tumorigenesis
(80). While AID-initiated DSBs are observed in the G1 phase of the
cell cycle (137), and CSR is likely completed before the cells transit
into the S phase, it has been suggested that homologous recom-
bination (HR)-dependent repair has a major role in providing
resistance to AID-induced off-target DNA-damage. This is based
on the observation that B cells deficient in the HR protein XRCC2
have significantly enhanced AID-dependent genome-wide DSBs
(138) (Figure 7). Notably, the interplay between AID-mediated
DNA breaks and HR repair pathway has been used in clinically
relevant studies wherein AID-expressing human chronic lym-
phocytic leukemia cells were shown to be hypersensitive to HR
inhibitors, possibly due to AID-dependent synthetic cytotoxicity
(139). Further studies, in clinical settings, should be an interesting
and possibly efficacious way to turn the mutator activity of AID
into a therapy for B cell malignancies.
PERSPECTIVE
The discovery of AID was a watershed event in the field of B
cell biology and in deciphering the underlying cause behind the
ontogeny of a large number of B cell lymphomas. We now have a
working model of how non-coding transcription and DNA deam-
ination initiate CSR and how general DNA repair proteins that
function in distinct pathways contribute to the process. Still, a
large number of unknowns plague the field. These include the
mechanisms that specifically recruit AID to the Ig loci, leaving
the rest of the genome largely untouched. We are yet to under-
stand the processes that subvert normal DNA repair machineries
and instead wield components of these pathways to promote
recombination of DSBs that could be over 100 kb apart. The mol-
ecular basis underlying the balance between normal and aberrant
repair requires further elucidation. Such basic knowledge can be
exploited to shift the fulcrum of repair judiciously in clinical
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settings of patients with immunodeficiency or lymphoid malig-
nancies to reap translational benefit. Finally, DSB response occurs
in, and is strongly influenced by the chromatin microenviron-
ment. The dynamics of chromatin compaction and relaxation
at DSBs are just beginning to unravel (140), but clearly much
more remains to be unearthed as to how the dynamics of his-
tone and DNA modifications impact and regulate a programed
DSB response that ensues during AID-orchestrated CSR. Address-
ing these exciting issues will be at the forefront of research in the
coming years.
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